EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells

Burak Kuzu, Derya Yetkin, Ceylan Hepokur iD, Oztekin Algul iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70078 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2025. Written by Burak Kuzu and 3 co-authors. Institution: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, Van, Türkiye. Major MEDLINE topics: Apoptosis, Benzoxazoles, Breast Neoplasms, Antineoplastic Agents. Cited 7 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY 4.0). Funded by: Van YYU BAP.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

This study presents the design, synthesis, and biological evaluation of a series of novel pyrrole‐tethered bisbenzoxazole (PTB) derivatives as potential apoptosis‐inducing agents targeting the MCF‐7 human breast cancer cell line. The anticancer activity of these compounds was evaluated in vitro using the MTT assay, with tamoxifen serving as the reference therapeutic agent. Compounds B8 , B14 , and B18 demonstrated remarkable cytotoxicity against MCF‐7 cells, exhibiting approximately 8‐fold lower IC 50 values compared to tamoxifen, while showing minimal effects on healthy fibroblasts. Further investigations revealed that these compounds effectively induced early‐stage apoptosis and selectively arrested the cell cycle at the G1 phase in cancer cells. Gene expression analysis confirmed selective activation of the caspase‐9‐mediated apoptotic pathway in MCF‐7 cells, providing insights into their underlying molecular mechanisms. These findings highlight the promising potential of PTB derivatives as potent anticancer agents, laying the groundwork for the development of targeted therapies for breast cancer that leverage apoptosis induction for improved therapeutic outcomes.

Subjects

MeSH terms (MEDLINE)

ApoptosisBenzoxazolesBreast NeoplasmsAntineoplastic AgentsPyrrolesHumansFemaleMCF-7 CellsDrug Screening Assays, AntitumorCaspase 9Structure-Activity RelationshipCell Proliferation

Author keywords

BisbenzoxazoleMTTapoptosiscell cyclecytotoxicitypyrrolesynthesis

Substances

BenzoxazolesAntineoplastic AgentsPyrrolesCaspase 9

Authors and institutions

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, Van, Türkiye.
  • Advance Technology Education Research and Application Centre, Mersin University, Mersin, Türkiye.
  • Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mersin University, Mersin, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, Türkiye.

ORCID profiles: Ceylan Hepokur, Oztekin Algul

Funding

  • Van YYU BAP

Cite

APA

Kuzu, B., Yetkin, D., Hepokur, C., & Algul, O. (2025). Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70078

Vancouver

Kuzu B, Yetkin D, Hepokur C, Algul O. Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70078

BibTeX
@article{Kuzu2025,
  author = {Kuzu, Burak and Yetkin, Derya and Hepokur, Ceylan and Algul, Oztekin},
  title = {Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70078}
}
Start for free →